Accéder au contenu
Merck

Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology.

eLife (2021-12-08)
Timothy M Errington, Alexandria Denis, Anne B Allison, Renee Araiza, Pedro Aza-Blanc, Lynette R Bower, Jessica Campos, Heidi Chu, Sarah Denson, Cristine Donham, Kaitlyn Harr, Babette Haven, Elizabeth Iorns, Jennie Kwok, Elysia McDonald, Steven Pelech, Nicole Perfito, Amanda Pike, Darryl Sampey, Michael Settles, David A Scott, Vidhu Sharma, Todd Tolentino, Angela Trinh, Rachel Tsui, Brandon Willis, Joshua Wood, Lisa Young
RÉSUMÉ

As part of the Reproducibility Project: Cancer Biology, we published Registered Reports that described how we intended to replicate selected experiments from 29 high-impact preclinical cancer biology papers published between 2010 and 2012. Replication experiments were completed and Replication Studies reporting the results were submitted for 18 papers, of which 17 were accepted and published by eLife with the rejected paper posted as a preprint. Here, we report the status and outcomes obtained for the remaining 11 papers. Four papers initiated experimental work but were stopped without any experimental outcomes. Two papers resulted in incomplete outcomes due to unanticipated challenges when conducting the experiments. For the remaining five papers only some of the experiments were completed with the other experiments incomplete due to mundane technical or unanticipated methodological challenges. The experiments from these papers, along with the other experiments attempted as part of the Reproducibility Project: Cancer Biology, provides evidence about the challenges of repeating preclinical cancer biology experiments and the replicability of the completed experiments.

MATÉRIAUX
Numéro du produit
Marque
Description du produit

Sigma-Aldrich
Insuline solution human, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
Anticorps monoclonal ANTI-FLAG® M2 antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Roche
Cocktails d′inhibiteurs de protéases Mini cOmplete, Tablets provided in a glass vial
Sigma-Aldrich
Anticorps monoclonal anti-β-actine antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Hydrocortisone, BioReagent, suitable for cell culture
Sigma-Aldrich
Kit de détection par PCR LookOut® pour mycoplasmes, Optimized for use with JumpStart Taq DNA Polymerase, D9307.
Sigma-Aldrich
Sodium selenite, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
Fluorure de phénylméthanesulfonyle solution, ~0.1 M in ethanol (T)
Sigma-Aldrich
Sous-unité B de la toxine cholérique, ≥95% (SDS-PAGE), lyophilized powder
First-strand cDNA Synthesis Kit, Cytiva 27-9261-01
Sigma-Aldrich
IgG1 Isotype Control from murine myeloma, clone MOPC 21, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-Vinculin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
ChIPAb+ triméthyl-histone H3 (Lys4) – Ensemble d′anticorps et d′amorces validé par ChIP, IgG monoclonale de lapin, from rabbit
Sigma-Aldrich
Tpl2 Kinase Inhibitor, The Tpl2 Kinase Inhibitor, also referenced under CAS 871307-18-5, controls the biological activity of Tpl2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.